Effect of Negative Pressure Wound Therapy on Wound Complications Post-Pancreatectomy by Kuncewitch, M. P. et al.
Journal Articles 
2019 
Effect of Negative Pressure Wound Therapy on Wound 
Complications Post-Pancreatectomy 
M. P. Kuncewitch 
Zucker School of Medicine at Hofstra/Northwell, mkuncewitc@northwell.edu 
A. U. Blackham 
C. J. Clark 
R. M. Dodson 
G. B. Russell 
See next page for additional authors 
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles 
 Part of the Surgery Commons 
Recommended Citation 
Kuncewitch MP, Blackham AU, Clark CJ, Dodson RM, Russell GB, Levine EA, Shen P. Effect of Negative 
Pressure Wound Therapy on Wound Complications Post-Pancreatectomy. . 2019 Jan 01; 85(1):Article 
5955 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/5955. Free full text 
article. 
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic 
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara 
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu. 
Authors 
M. P. Kuncewitch, A. U. Blackham, C. J. Clark, R. M. Dodson, G. B. Russell, E. A. Levine, and P. Shen 
This article is available at Donald and Barbara Zucker School of Medicine Academic Works: 
https://academicworks.medicine.hofstra.edu/articles/5955 
Effect of Negative Pressure Wound Therapy on Wound 
Complications Post-Pancreatectomy
MICHAEL P. KUNCEWITCH, M.D.*, AARON U. BLACKHAM, M.D.†, CLANCY J. CLARK, M.D.*, 
REBECCA M. DODSON, M.D.*, GREGORY B. RUSSELL, M.S.‡, EDWARD A. LEVINE, M.D.*, 
PERRY SHEN, M.D.*
*Wake Forest Baptist Medical Center, Department of General Surgery, Section of Surgical 
Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
†Division of Surgical Oncology, Lehigh Valley Physician Group, Allentown, Pennsylvania
‡Department of Biostatistics, Wake Forest, University, Winston-Salem, North Carolina
Abstract
Surgical site infection (SSI) and incisional hernia are common complications after major 
pancreatectomy. We investigated the effects of negative pressure wound therapy (NPWT) on short- 
and long-term wound outcomes in patients undergoing pancreatectomy. A randomized controlled 
trial comparing the effect of NPWT with standard surgical dressing (SSD) on wounds was 
performed in 265 patients undergoing open gastrointestinal resections from 2012 to 2016. We 
performed a subset analysis of 73 patients who underwent pancreatectomy. Wound complications 
in the first 30 days and incisional hernia rates were assessed. There were 33 (45%) female patients 
in the study and the average BMI was 27.6. The pancreaticoduodectomy rate was 68 per cent, 
whereas 27 per cent of patients underwent distal or subtotal pancreatectomy, and 4 per cent total 
pancreatectomy. Incisional hernia rates were 32 per cent and 14 per cent between the SSD and 
NPWT groups, respectively (P = 0.067). In the SSD (n = 37) and NPWT (n = 36) cohorts, the 
superficial SSI, deep SSI, seroma, and dehiscence rates were 16 per cent and 14 per cent (P > 
0.99), 5 per cent and 8 per cent (P = 0.67), 16 per cent and 11 per cent (P = 0.74), and 5 per cent 
and 3 per cent (P ≥ 0.99), respectively. After adjusting for pancreatic fistula and delayed gastric 
emptying, no statistically significant differences in the primary outcomes were observed. These 
findings were true irrespective of the type of resection performed. Short- and long-term wound 
complications were not improved with NPWT. We observed a trend toward decreased incisional 
hernia rates in patients treated with NPWT. Owing to the multifactorial nature of wound 
complications, it is yet to be determined which cohorts of pancreatectomy patients will benefit 
from NPWT.
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SURGEONS WHO TREAT disorders of the pancreas are accustomed to giving considerable 
attention to the incidence, management, and potential prevention of complications after 
pancreatectomy. Pancreatic fistula is typically the most studied of these complications and 
perhaps the one most discussed with patients while obtaining informed consent. It may 
therefore be easy to overlook the notion that wound complications following pancreatectomy 
happen with similar or even greater frequency. Several recent studies put the incidence of 
surgical site infection (SSI) after major pancreatectomy between 10 and 35 per cent.1–4 With 
an average cost of approximately US $11,000 per SSI after pancreatectomy and an 
additional 6.5 days hospital stay, this represents a great cost burden to health-care systems.3 
SSI represents a major health burden to patients as well when considering that SSI after 
major surgery has been associated with a doubling in the risk of postoperative mortality as 
well as increased likelihood of hospital readmission and need for ICU care.5
Incisional hernia is another potentially adverse out-come that can cause significant 
morbidity for patients undergoing major pancreatectomy. One recent study found that 
incisional hernia may incur in up to 50 per cent of patients undergoing open pancreatectomy.
6
 This can be potentially detrimental to a patient’s quality of life after an operation already 
known to carry considerable morbidity risks. Furthermore, many major pancreatectomies are 
performed for tumors that may portend a greatly shortened life expectancy, thereby ruling 
certain patients out for potentially complex ventral hernia repair that might otherwise 
improve their quality of life.
Last, it should be noted that there is a strong association between SSI and subsequent 
incisional hernia after laparotomy, so efforts aimed at curbing SSI could reasonably be 
considered to be preventative toward incisional hernia as well.7 One such method that has 
been considered as a potentially prophylactic measure toward these ends is negative pressure 
wound therapy (NPWT). We previously reported the results of a Phase II randomized 
controlled trial using NPWT in an attempt to decrease SSI in patients undergoing 
laparotomy for various abdominal malignancies.8 We herein report the results on short- and 
long-term wound out-comes on a subset of these patients undergoing major pancreatectomy 
(pancreaticoduodenectomy (PD), total pancreatectomy, or distal/subtotal pancreatectomy) 
randomized to prophylactic application of NPWT versus standard surgical dressing (SSD) at 
the time of primary wound closure.
Materials and Methods
This study was approved by the Protocol Review Committee of the Wake Forest Baptist 
Comprehensive Cancer Center and the Wake Forest University Institutional Review Board. 
As previously reported, we performed a prospective Phase II randomized controlled trial 
assessing the differences in SSI rates for patients undergoing open oncologic gastrointestinal 
resections from 2012 to 2016, whose wounds were dressed with either a SSD or NPWT at 
the time of primary closure.8 Eligible participants were those patients aged 18 years or older 
who were able to understand and sign written informed consent and who underwent a 
pancreatectomy via a midline laparotomy incision with a class II (clean-contaminated) case. 
Those patients undergoing a laparoscopic-assisted procedure were included as long as an 
incision of no less than 7.5 cm was required for either a hand port or specimen extraction. 
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Surgical drains were permitted in the study as long as the drain exited the abdominal wall at 
a site remote from the primary incision. Exclusion criteria included any wound that was not 
class II, purely laparoscopic cases, patient history of allergic reaction to adhesives, and 
steroid or immunosuppressive use within three months of the planned operation.
For the present study, we performed a subset of analysis of 73 of the original 265 patients 
who underwent a major pancreatectomy to see whether there was any difference in the rates 
of SSI at 30 days from operation for this particular cohort. The technique for application of 
the NPWT has been previously described.9 To determine whether an SSI occurred, study 
members performed wound checks that included a daily assessment of the incision and 
abdominal wall during the patient’s postoperative hospital stay as well as any readmissions 
or outpatient clinic visits until 30 days after surgery. Team members were instructed to 
assess wounds by using an incision assessment form that documented wound status 
according to SSD soilage level or NPWT drainage quantity, cellulitis, seroma, hematoma, 
dehiscence, or organ/space SSI. Patients were considered to develop an SSI if they met the 
criteria for either a superficial or deep SSI as defined by the Centers for Disease Control.10 
Both the SSD and NPWT were discontinued on postoperative day 4 as part of the study 
protocol. If any wound in either study arm was found to be productive of either pancreatic or 
enteric effluent before this, the dressing was to be discontinued and replaced with a wet-to-
dry dressing.
To ascertain the medium- to long-term effects of NPWT on laparotomy incisions after major 
pancreatectomy, we also analyzed as a primary outcome the incidence of incisional hernia in 
the SSD and NPWT groups. Patients were assessed at postoperative clinic visits for clinical 
evidence of incisional hernia as determined by a fascial defect appreciated on physical 
examination of the abdomen. Wound assessments were documented in the patient record at 
the initial postoperative visit, as well as at 6- and 12-month follow-up intervals. Assessments 
continued at yearly intervals thereafter or until the patient was lost to follow-up or died.
Secondary outcomes that were measured included the incidence of pancreatic fistula and 
delayed gastric emptying (DGE) because these factors were considered to have the potential 
to independently contribute to wound healing problems, thereby confounding the 
contribution of NPWT to the study. For purposes of this study, pancreatic fistula was defined 
as a surgical drain amylase level greater than three times the upper limit of normal for serum 
amylase after postoperative day 3.11 Delayed gastric emptying was defined according to the 
2007 International Study Group of Pancreas Surgery guidelines.12
Statistical Analysis
Descriptive statistics, including means and standard deviations for continuous measures and 
frequencies and percentages for categorical variables, were calculated for all study measures. 
To test for differences in demographic measures between study assignments, independent t 
tests were used for continuous measures and Fisher’s exact tests were used for categorical 
data. To assess the strength of the relationship with hernia and SSI, single and multiple 
variate logistic regression models were created, with the independent study variables as 
predictors. SAS (version 9.4, Cary, NC) was used for all analyses.
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Results
From 2012 to 2016, there were 73 patients undergoing major pancreatectomy out of 265 
patients who were analyzed in the original study examining rates of SSI in patients receiving 
NPWT after open oncologic abdominal resections. Patients were followed for a median 
duration of 11 (range, 1–48) months before death or loss to follow-up. The average age of 
patients treated in both groups was 65 years (age range, 35–85 years), with 45 per cent of the 
patients being women. Both the SSI and NPWT groups were demographically similar in 
terms of race, BMI, performance status, medical comorbidities, tobacco use, previous 
abdominal surgery, and whether or not study participants received neoadjuvant 
chemotherapy or radiation (Table 1). Most resections in the study were performed for 
pancreatic adenocarcinoma (51%). In both the SSD and NPWT groups, respectively, the 
most common type of resection was PD (65% vs 72%), with the remaining patients 
undergoing similar rates of distal, subtotal, and total pancreatectomy between the groups. 
There were also no statistically different differences in the use of laparoscopy, operative 
time, or estimated blood loss in those patients whose wounds were dressed with SSD or 
NPWT. There was a trend toward more frequent need for blood transfusion in the SSD 
group compared with the NPWT group (eight patients vs two patients), but this also did not 
reach statistical significance (P = 0.085; Table 2).
The rates of any degree of SSI were equal (22%; P > 0.99) in both the SSD and NPWT 
groups. This was borne out with similar rates in the SSD and NPWT cohorts, respectively, 
for superficial SSI (16% vs 14%; P > 0.99), deep SSI (5% vs 8%; P = 0.67), seroma 
formation (16% vs 11%; P = 0.74), and wound dehiscence rates (5% vs 3%; P = 0.99; Fig. 
1). A similar number of patients required that their wounds be opened for any reason in the 
SSD and NPWT groups (35% vs 25%, respectively; P = 0.45) and no statistically significant 
difference was appreciated in the need for readmission within 30 days of operation owing to 
a wound complication (15% vs 7%; P = 0.26; Fig. 2).
The rates of incisional hernia as determined by postoperative clinical examination in the 
SSD and NPWT groups were 32 per cent and 14 per cent, respectively (P = 0.067; Fig. 2). 
Resection-specific incisional hernia rates for those patients undergoing PD, distal/subtotal 
pancreatectomy, and total pancreatectomy were 25 per cent, 17 per cent, and 50 per cent, 
respectively (Fig. 3). NPWT was not found to be preventative toward incisional hernia in 
any of these groups (all P > 0.33). Of the 17 total patients who developed an incisional 
hernia between the two treatment arms, 4/17 (24%) subsequently underwent an incisional 
hernia repair.
In those patients with laparotomy incisions dressed with SSD or NPWT, respectively, the 
incidence of postoperative pancreatic fistula (22% vs 31%, P = 0.43) and DGE (11% vs 8%, 
P > 0.99) was not statistically different (Fig. 2). Neither univariate nor multivariate analysis 
identified any demographic or operative factors associated with a difference in incisional 
hernia rates in either treatment arm (Table 3).
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Discussion
SSI is a major driver of patient morbidity and hospital cost. As a result, investigators in 
various surgical fields have turned their gaze to the NPWT in the hopes of finding a better 
way to manage elective wounds and reduce this burden.13–15 For the patient with pancreatic 
malignancy, however, the potential benefits of avoiding an SSI could also include prolonged 
survival, as SSI after pancreatectomy has been demonstrated to lead to a delay in receiving 
adjuvant treatment.16
The purported benefits of NPWT in improving wound healing include the abilities to remove 
excess fluid from the wound microenvironment, to reduce shear stresses and tissue hypoxia 
on the wound edges, and to stimulate the release of vascular endothelial growth factor in the 
wound milieu.17,18 In theory, the application of NPWT to an elective midline laparotomy 
wound might then decrease the incidence of superficial SSI at the very least. It stands to 
reason that a corollary to such a benefit would be an associated decrease in postoperative 
incisional hernia. In practice, however, this line of reasoning has not yet been successfully 
proven. We recently published the results of a Phase II randomized controlled trial in 
patients undergoing laparotomy incisions for gastrointestinal malignancies that showed no 
statistically significant difference in the rates of either superficial or deep SSI for patients 
whose wounds were treated with either SSD or NPWT at the time of primary closure.8 The 
design of that trial, however, was limited to a 30-day follow-up and intended only to assess 
the short-term effects of NPWT on laparotomy for oncologic resection. This study includes a 
median patient follow-up of 11 months, during which we were able to perform interval 
clinical examinations to assess patients for the presence of an incisional hernia.
Pancreatectomy is often performed in patients with pancreas adenocarcinoma, an entity that 
can carry a poor prognosis. For this reason, the importance of emphasizing a patient’s 
quality of life after resection is magnified, a sentiment that is gaining considerable traction 
in the world of medicine.19 Identifying any potential benefit of NPWT in preventing 
incisional hernia could greatly benefit the pancreatectomy patient as patients with incisional 
hernia can experience a detrimental impact on their quality of life.20 Moreover, many 
patients with pancreatic pathologies might not be good surgical candidates for ventral hernia 
repair after their major pancreatectomy. This is suggested by the fact that in our study, only 4 
of 17 patients who had a postoperative hernia appreciated on physical examination 
underwent subsequent surgical repair of that hernia. Although we did observe a trend toward 
improvement in incisional hernia rates after major pancreatectomy with NPWT, this was not 
statistically significant.
However, the 14 per cent rate of incisional hernia using NPWT compared with 32 per cent 
without should not be ignored and may simply be a result of the pancreas subset of the initial 
study being underpowered. There are several factors that may explain a correlation between 
NPWT and a decreased hernia rate. One potential mechanism of action of NPWT is to 
provide a localized abdominal binder-like effect on the fascia and soft tissues of the 
abdominal wall, thereby counteracting the sheering forces and lateral tensile forces placed 
on the wound post-operatively.21 Another possible explanation for the association between 
NPWT and decreased hernia rate is its effect on local interstitial fluid accumulation. 
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Although we did not observe a statistically significant difference in the rate of seroma 
formation with the use of NPWT, it is still likely that NPWT reduces local tissue edema, 
which should lead to an increase in local tissue perfusion.22
In addition, it has been demonstrated that treating a wound with subatmospheric pressures of 
125 mmHg can result in up to a 4-fold increase in perfusion of the tissues at the edges of the 
wound.23 Finally, the use of NPWT has been demonstrated to apply a constant, equally 
distributed mechanical stress to the tissues at the edge of the porous foam used in NPWT.24 
Unlike lateral tensile forces or shearing forces from abdominal wall movement that may 
distract the fascia as it attempts to heal, these local mechanical forces may act increase 
angiogenesis and upregulate genes leading to increased fibroblast activity and collagen turn-
over.25‘ 26 Together, all of these factors may lead to an optimization of fascial healing with a 
subsequent decrease in the likelihood of an incisional hernia.
One potential reason why we did not observe a statistically significant difference in 
incisional hernia after pancreatectomy with NPWT may be the duration of therapy itself. 
The optimal duration of NPWT when applied to a primary abdominal incision has not yet 
been determined. We chose four days of therapy based on the extensive experience of the 
plastic surgeons at our institution, but that may not be the optimal length of time when 
considering healing of the abdominal fascia. It is then possible that a longer period of 
NPWT may be most beneficial, with patient length of stay acting to limit duration on 
practicality and cost bases. In any case, perhaps other ongoing trials evaluating NPWT for 
primary transabdominal incisions can guide us toward the optimal duration of therapy.
Our assessment of the rates of incisional hernia was also limited by the fact that this study 
only sought to establish the presence or absence of a clinically appreciable incisional hernia. 
We did not measure the size of the hernia or the impact on a patient’s performance status or 
quality of life. We did not assess the hernias for symptomatology or whether the patient 
desired surgical repair. Another limitation of the study is the median follow-up of 11 
months. Although most incisional hernias will present within the first postoperative year, a 
significant proportion of incisional hernias can be first diagnosed at two to five years from 
the index operation.27 For this reason, it is possible the incidence of incisional hernia in 
either or both of our treatment groups would change at longer follow-up. This limited 
follow-up may support the notion that, although prevention of incisional hernia in this study 
could not be demonstrated, the trend toward statistical significance might merit further 
study.
Conclusion
The use of NPWT in midline laparotomy incisions for patients undergoing major 
pancreatectomy did not demonstrate a difference in the rates of SSI or incisional hernia. 
Based on the results of this study, NPWT cannot be recommended to prevent short- or long-
term wound complications in patients undergoing major pancreatectomy.
KUNCEWITCH et al. Page 6
Am Surg. Author manuscript; available in PMC 2019 September 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
REFERENCES
1. Ceppa EP, Pitt HA, House MG, et al. Reducing surgical site infections in hepatopancreatobiliary 
surgery. HPB (Oxford) 2013; 15:384–91. [PubMed: 23557410] 
2. Okano K, Hirao T, Unno M, et al. Postoperative infectious complications after pancreatic resection. 
Br J Surg 2015;102: 1551–60. [PubMed: 26387569] 
3. Sanford DE, Strasberg SM, Hawkins WG, et al. The impact of recent hospitalization on surgical site 
infection after a pancreatectomy. HPB (Oxford) 2015;17:819–23. [PubMed: 26221859] 
4. You L, Zhao W, Hong X, et al. The effect of body mass index on surgical outcomes in patients 
undergoing pancreatic resection: a systematic review and meta-analysis. Pancreas 2016;45:796–805. 
[PubMed: 27295531] 
5. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: 
attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp 
Epidemiol 1999;20:725–30. [PubMed: 10580621] 
6. Baucom RB, Ousley J, Beveridge GB, et al. Cancer survivorship: defining the incidence of 
incisional hernia after resection for intra-abdominal malignancy. Ann Surg Oncol 2016;23:764–71. 
[PubMed: 27743227] 
7. Itatsu K, Yokoyama Y, Sugawara G, et al. Incidence of and risk factors for incisional hernia after 
abdominal surgery. Br J Surg 2014;101:1439–47. [PubMed: 25123379] 
8. Shen P, Blackham AU, Lewis S, et al. Phase II randomized trial of negative-pressure wound therapy 
to decrease surgical site infection in patients undergoing laparotomy for gastrointestinal, pancreatic, 
and peritoneal surface malignancies. J Am Coll Surg 2017;224:726–37. [PubMed: 28088597] 
9. Blackham AU, Farrah JP, McCoy TP, et al. Prevention of surgical site infections in high-risk patients 
with laparotomy incisions using negative-pressure therapy. Am J Surg 2013;205:647–54. [PubMed: 
23375758] 
10. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 
1999. Centers for disease control and prevention (CDC) hospital infection control practices 
advisory committee. Am J Infect Control 1999;27:97–132; quiz 133–134; discussion 196. 
[PubMed: 10196487] 
11. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group 
(ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after. Surgery 
2017;161: 584–91. [PubMed: 28040257] 
12. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a 
suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 
2007;142:761–8. [PubMed: 17981197] 
13. Stannard JP, Volgas DA, McGwin G, et al. Incisional negative pressure wound therapy after high-
risk lower extremity fractures. J Orthop Trauma 2012;26:37–42. [PubMed: 21804414] 
14. Atkins BZ, Wooten MK, Kistler J, et al. Does negative pressure wound therapy have a role in 
preventing poststernotomy wound complications? Surg Innov 2009;16:140–6. [PubMed: 
19460818] 
15. Lynam S, Mark KS, Temkin SM. Primary placement of incisional negative pressure wound therapy 
at time of laparotomy for gynecologic malignancies. Int J Gynecol Cancer 2016;26:1525–9. 
[PubMed: 27488215] 
16. Akahori T, Sho M, Tanaka T, et al. Factors associated with failure to complete adjuvant 
chemotherapy in pancreatic cancer. Am J Surg 2016;211:787–92. [PubMed: 26846177] 
17. Erba P, Ogawa R, Ackermann M, et al. Angiogenesis in wounds treated by microdeformational 
wound therapy. Ann Surg 2011;253:402–9. [PubMed: 21217515] 
18. Scalise A, Calamita R, Tartaglione C, et al. Improving wound healing and preventing surgical site 
complications of closed surgical incisions: a possible role of incisional negative pressure wound 
therapy. A systematic review of the literature. Int Wound J 2016;13:1260–81. [PubMed: 
26424609] 
19. Borgstrom E Being mortal: illness, medicine, and what matters in the end, by atul gawande. 
Anthropol Med 2015;22: 333–5. [PubMed: 27454565] 
KUNCEWITCH et al. Page 7
Am Surg. Author manuscript; available in PMC 2019 September 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20. Krpata DM, Schmotzer BJ, Flocke S, et al. Design and initial implementation of HerQLes: a 
hernia-related quality-of-life survey to assess abdominal wall function. J Am Coll Surg 2012; 
215:635–42. [PubMed: 22867715] 
21. Thompson JT, Marks MW. Negative pressure wound therapy. Clin Plast Surg 2007;34:673–84. 
[PubMed: 17967622] 
22. Banwell PE, Musgrave M. Topical negative pressure therapy: mechanisms and indications. Int 
Wound J 2004;1:95–106. [PubMed: 16722882] 
23. Morykwas MJ, Argenta LC, Shelton-Brown EI, et al. Vacuum-assisted closure: a new method for 
wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553–
62. [PubMed: 9188970] 
24. Swartz MA, Tschumperlin DJ, Kamm RD, et al. Mechanical stress is communicated between 
different cell types to elicit matrix remodeling. Proc Natl Acad Sci U S A 2001;98:6180–5. 
[PubMed: 11353845] 
25. Ryan TJ, Barnhill RL. Physical factors and angiogenesis. Ciba Found Symp 1983;100:80–94. 
[PubMed: 6197263] 
26. Kessler D, Dethlefsen S, Haase I, et al. Fibroblasts in mechanically stressed collagen lattices 
assume a “synthetic” phenotype. J Biol Chem 2001;276:36575–85. [PubMed: 11468280] 
27. Bensley RP, Schermerhorn ML, Hurks R, et al. Risk of late-onset adhesions and incisional hernia 
repairs after surgery. J Am Coll Surg 2013;216:1159–67, 1167.e1–12. [PubMed: 23623220] 
KUNCEWITCH et al. Page 8
Am Surg. Author manuscript; available in PMC 2019 September 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Incidence rates of wound complications by study arm. All P > 0.05.
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Fig. 2. 
Rate of postoperative complications by study arm. POPF, postoperative pancreatic fistula. 
All P > 0.05.
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Fig. 3. 
Overall rate of incisional hernia by resection type.
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